Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Dr. Peter Attia

👤 Speaker
11186 total appearances

Appearances Over Time

Podcast Appearances

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

And what was the internal focus then?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

And what was the internal focus then?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

So who were your direct reports, the provost?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

So who were your direct reports, the provost?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

This would be something you did as a scientist, not necessarily as the chancellor. Not as the chancellor. The chancellors weren't doing this all the time.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

This would be something you did as a scientist, not necessarily as the chancellor. Not as the chancellor. The chancellors weren't doing this all the time.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

So then let's get to the next chapter. What all of a sudden in 2013, 2014 leads to the next transition to being the CEO of the Bill and Melinda Gates Foundation?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

So then let's get to the next chapter. What all of a sudden in 2013, 2014 leads to the next transition to being the CEO of the Bill and Melinda Gates Foundation?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Was he still there?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Was he still there?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

I assume that the rationale for that was obviously their focus is on global health. And you have the background in the clinical side, the research side, the epidemiologic side, the management side. So there's kind of those are four legs of a chair. Were there other things that I'm missing that they felt were kind of essential pillars?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

I assume that the rationale for that was obviously their focus is on global health. And you have the background in the clinical side, the research side, the epidemiologic side, the management side. So there's kind of those are four legs of a chair. Were there other things that I'm missing that they felt were kind of essential pillars?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

But those points of view don't strike me as mutually exclusive for an organization with enormous resources.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

But those points of view don't strike me as mutually exclusive for an organization with enormous resources.

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

So how did you weigh this decision?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

So how did you weigh this decision?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Were they surprised? Did they try to talk you out of this?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Were they surprised? Did they try to talk you out of this?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Okay. So you head up to Seattle now. Yes. When you show up to the foundation, how many employees are there? What does it look like? It's a not-for-profit, but does it run like Microsoft? I mean, how does it operate?

The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.

Okay. So you head up to Seattle now. Yes. When you show up to the foundation, how many employees are there? What does it look like? It's a not-for-profit, but does it run like Microsoft? I mean, how does it operate?